PMID- 37360620
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231101
IS  - 2628-491X (Electronic)
IS  - 2628-491X (Linking)
VI  - 1
IP  - 4
DP  - 2020 Dec
TI  - VALIDA project: Validation of allergy in vitro diagnostics assays (Tools and 
      recommendations for the assessment of in vitro tests in the diagnosis of 
      allergy).
PG  - 20200051
LID - 10.1515/almed-2020-0051 [doi]
LID - 20200051
AB  - In vitro allergen-specific immunoglobulin E (IgE) detection and quantification 
      tests are routinely performed in clinical laboratories to diagnose patients with 
      a suspected allergy. Numerous commercial assays are available to test for 
      allergies, but the results can vary widely, thereby influencing both diagnosis 
      and treatment. Given the challenges posed by differences in the various assays 
      for in vitro determination of specific IgE, a group of experts has compiled in a 
      document a series of recommendations on the implications that the use of a 
      certain in vitro technique may have and the impact on the management of the 
      allergic patient that the differences between the various techniques represent. 
      The reading and analysis of this consensus document will help to understand the 
      implications of the change of in vitro diagnostic method in the management of the 
      patient with allergy, in the quality of life and in the socioeconomic costs 
      associated with the disease.
CI  - (c) 2020 Maria L. Casas et al., published by De Gruyter, Berlin/Boston.
FAU - Casas, Maria L
AU  - Casas ML
AD  - Clinical Analysis Service, Fundacion Alcorcon University Hospital, Alcorcon, 
      Madrid, Spain.
AD  - Spanish Society of Laboratory Medicine (SEQC-ML), Barcelona, Spain.
FAU - Esteban, Angel
AU  - Esteban A
AD  - Spanish Society of Laboratory Medicine (SEQC-ML), Barcelona, Spain.
AD  - Clinical Analysis Service, University General Hospital of Alicante, Alicante, 
      Spain.
FAU - Gonzalez-Munoz, Miguel
AU  - Gonzalez-Munoz M
AD  - Immunology Service, La Paz University Hospital, Madrid, Spain.
AD  - Spanish Society of Immunology (SEI), Barcelona, Spain.
FAU - Labrador-Horrillo, Moises
AU  - Labrador-Horrillo M
AD  - Allergology Service, Vall d'Hebron University Hospital, Barcelona, Spain.
AD  - Spanish Society of Allergology and Clinical Immunology (SEAIC), Madrid, Spain.
FAU - Pascal, Mariona
AU  - Pascal M
AD  - Spanish Society of Immunology (SEI), Barcelona, Spain.
AD  - Spanish Society of Allergology and Clinical Immunology (SEAIC), Madrid, Spain.
AD  - Immunology Service, CBD, Hospital Clinic de Barcelona, IDIBAPS, Universitat de 
      Barcelona, Barcelona, Spain.
AD  - ARADyAL Research Network, Carlos III Institute, Madrid, Spain.
FAU - Teniente-Serra, Aina
AU  - Teniente-Serra A
AD  - Spanish Society of Immunology (SEI), Barcelona, Spain.
AD  - Immunology Service, LCMN, Germans Trias i Pujol University Hospital, Badalona, 
      Spain.
LA  - eng
LA  - spa
PT  - Journal Article
PT  - Review
DEP - 20200821
PL  - Germany
TA  - Adv Lab Med
JT  - Advances in laboratory medicine
JID - 9918284273306676
PMC - PMC10197418
OTO - NOTNLM
OT  - allergy
OT  - diagnosis in vitro
OT  - immunoglobulin E
OT  - recommendations
COIS- Competing interests: Authors state no conflict of interest.
EDAT- 2020/08/21 00:00
MHDA- 2020/08/21 00:01
PMCR- 2020/08/21
CRDT- 2023/06/26 12:39
PHST- 2020/02/20 00:00 [received]
PHST- 2020/05/05 00:00 [accepted]
PHST- 2020/08/21 00:01 [medline]
PHST- 2020/08/21 00:00 [pubmed]
PHST- 2023/06/26 12:39 [entrez]
PHST- 2020/08/21 00:00 [pmc-release]
AID - almed-2020-0051 [pii]
AID - 10.1515/almed-2020-0051 [doi]
PST - epublish
SO  - Adv Lab Med. 2020 Aug 21;1(4):20200051. doi: 10.1515/almed-2020-0051. eCollection 
      2020 Dec.